HEPATOLOGY INFORMATION CENTER

News

Topline Data Announced for Selonsertib in Patients With Compensated Cirrhosis Due to NASH

Topline Data Announced for Selonsertib in Patients With Compensated Cirrhosis Due to NASH

Topline data from the Phase 3 STELLAR-4 trial showed that selonsertib, an investigational treatment for patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH), was not associated with a significant improvement in fibrosis without worsening of NASH.

Gender Gap Seen in Accessing Alcohol Treatment With Cirrhosis

Women less likely to be treated than men; treatment visit, medication tied to improved 1-year outcomes.

CDC: Proportion of Increased-Risk Deceased Organ Donors on Rise

Increased-risk donors significantly more likely to have positive HBV, HCV screening results.

Features

ACIP Updates Recommendations for US Adult Immunization Schedule

ACIP Updates Recommendations for US Adult Immunization Schedule

The ACIP and CDC have approved and released 2019 recommendations for the adult immunization schedule in the US.

Universal vs Risk-Based Screening in Pregnancy: An Expert Weighs In

Universal vs Risk-Based Screening in Pregnancy: An Expert Weighs In

There is a lack of consensus among experts and professional organizations whether HCV screening in pregnant women should be risk based or universal.

Sign Up for Free e-newsletters